Viewing Study NCT02572492


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-26 @ 5:55 AM
Study NCT ID: NCT02572492
Status: UNKNOWN
Last Update Posted: 2018-08-17
First Post: 2015-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support
Sponsor: Henrik Gregersen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module